Filter
1816
Text search:
ART
therapy
Featured
184
603
Language
Document type
1176
232
192
85
37
35
33
6
5
4
4
3
1
1
Countries
119
75
64
63
53
50
48
48
44
40
34
34
31
30
27
27
26
22
22
22
22
20
20
17
16
16
16
16
16
14
13
11
10
10
9
7
7
7
6
5
5
5
5
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
923
155
77
54
44
36
13
1
Toolboxes
250
225
124
56
42
34
31
30
29
19
17
17
12
11
10
10
9
8
6
6
5
4
4
1
1
Technical Brief
В сводном руководстве изложены меры общественного здравоохранения применительно к ВИЧ-инфекции, вирусным гепатитам и инфекциям, передаваемым половым путем (ИПП
...
Educational Booklet
EDCTP Stakeholder meeting
Topics in Antiviral Medicine, volume 33 Issue 2 May 2025
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV K-19 Tuberculosis/HIV Coinfection
Updated: September 12, 2024 Key Considerations and Recommendations
A toolkit for health facilities. This toolkit highlights successful differentiated-care approaches implemented in a number of settings and countries in sub-Saharan Africa. The toolkit will be further updated as more experience is gained with these and similar
approaches
Pathogens 2022, 11, 33. https://doi.org/10.3390/pathogens11010033
Progress report and road map. Countries included in this report: Algeria, Afghanistan, Bahrain, Djibouti, Egypt, the Islamic Republic of Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Qatar, State of Palestine, Saudi Arabia, Somalia, Sudan, the Syrian Arab Republic, Tunisia, Un
...
SOP number SOP000108/2020
These guidelines focus on the provision of PrEP as part of comprehensive combination prevention,
drawing on implementation and research evidence and WHO recommendations.
PLoS ONE 18(12): e0295920. https://doi.org/10.1371/journal.pone.0295920. PLHIV were largely unaware and sceptical of U = U as the message appeared to contradict
the mainstream HIV prevention clinical guidance.
Multi-month dispensing (MMD) is the prescribing and dispensing of three to six months of antiretrovirals
(ARV) and other medicines required for treatment of people living with HIV (PLHIV). This approach is in
contrast to the current standard of care approach where drug dispensing requires monthly
...
Indicators and questions to monitor progress towards the Global AIDS Strategy 2026-2031 targets
We created this booklet to share our patients’ stories with a larger community. Too many historical injustices go unacknowledged in Iraq, and human rights abuses continue to this day. We feel it is essential to uncover these injustices and help our patients speak out, in the hope that one day all
...
